BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ita K, Ashong S. Percutaneous Delivery of Antihypertensive Agents: Advances and Challenges. AAPS PharmSciTech 2020;21:56. [PMID: 31909450 DOI: 10.1208/s12249-019-1583-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ita K, Ukaoma M. Progress in the transdermal delivery of antimigraine drugs. Journal of Drug Delivery Science and Technology 2022;68:103064. [DOI: 10.1016/j.jddst.2021.103064] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Despotopoulou D, Lagopati N, Pispas S, Gazouli M, Demetzos C, Pippa N. The technology of transdermal delivery nanosystems: from design and development to preclinical studies. Int J Pharm 2021;:121290. [PMID: 34788674 DOI: 10.1016/j.ijpharm.2021.121290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhang L, Guo R, Wang S, Yang X, Ling G, Zhang P. Fabrication, evaluation and applications of dissolving microneedles. Int J Pharm 2021;604:120749. [PMID: 34051319 DOI: 10.1016/j.ijpharm.2021.120749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
4 Moniz T, Costa Lima SA, Reis S. Marine polymeric microneedles for transdermal drug delivery. Carbohydr Polym 2021;266:118098. [PMID: 34044917 DOI: 10.1016/j.carbpol.2021.118098] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
5 Zhang Q, Feng Z, Ren W, Zhao Y, Dushkin AV, Su W. Preparation of olmesartan medoxomil solid dispersion with sustained release performance by mechanochemical technology. Drug Deliv Transl Res 2021. [PMID: 33860449 DOI: 10.1007/s13346-021-00959-w] [Reference Citation Analysis]
6 Yang Q, Zhong W, Xu L, Li H, Yan Q, She Y, Yang G. Recent progress of 3D-printed microneedles for transdermal drug delivery. International Journal of Pharmaceutics 2021;593:120106. [DOI: 10.1016/j.ijpharm.2020.120106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
7 Bhudia RP. Treatment of the hypertensive patient in 2030. J Hum Hypertens 2021;35:818-20. [PMID: 33127958 DOI: 10.1038/s41371-020-00437-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]